Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionHSGFX - Hussman Strategic Growth Fund
Latest Disclosed Ownership80,000 shares
Latest Disclosed Value $ 1,980,800
HSGFX - Hussman Strategic Growth Fund reports 20.00% decrease in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On May 29, 2026 - HSGFX - Hussman Strategic Growth Fund filed a NPORT-P form disclosing ownership of 80,000 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $1,980,800 USD as of March 31, 2026. The entity filed a previous NPORT-P on February 27, 2026 disclosing 100,000 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of -20.00% during the quarter. The current value of the position is $2,519,200 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 80,000 -20,000 -20.00 1,981 -15.17 0.5006
2026-02-27 2025-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 100,000 -40,000 -28.57 2,334 -15.37 0.6925
2025-12-01 2025-09-30 NP Catalyst Pharmaceutical EC US14888U1016 140,000 0 0.00 2,758 -9.22 0.7633
2025-08-28 2025-06-30 NP Catalyst Pharmaceutical EC US14888U1016 140,000 60,000 75.00 3,038 56.60 0.8376
2025-05-29 2025-03-31 NP Catalyst Pharmaceutical EC US14888U1016 80,000 -20,000 -20.00 1,940 -7.04 0.5822
2025-02-28 2024-12-31 NP Catalyst Pharmaceutical EC US14888U1016 100,000 0 0.00 2,087 4.98 0.7167
2024-11-27 2024-09-30 NP Catalyst Pharmaceutical EC US14888U1016 100,000 0 0.00 1,988 28.34 0.6374
2024-08-28 2024-06-30 NP Catalyst Pharmaceutical EC US14888U1016 100,000 0 0.00 1,549 -2.82 0.4785
2024-05-30 2024-03-31 NP Catalyst Pharmaceutical EC US14888U1016 100,000 -50,000 -33.33 1,594 -36.77 0.4678
2024-02-29 2023-12-31 NP Catalyst Pharmaceutical EC US14888U1016 150,000 0 0.00 2,522 43.81 0.6685
2023-11-28 2023-09-30 NP Catalyst Pharmaceutical EC US14888U1016 150,000 60,000 66.67 1,754 45.00 0.3840
2023-08-29 2023-06-30 NP Catalyst Pharmaceutical EC US14888U1016 90,000 0 0.00 1,210 -18.97 0.2594
2023-05-26 2023-03-31 NP Catalyst Pharmaceutical Partners EC US14888U1016 90,000 30,000 50.00 1,492 33.69 0.2818
2023-02-28 2022-12-31 NP Catalyst Pharmaceutical Partners EC US14888U1016 60,000 0 0.00 1,116 45.12 0.2058
2022-11-29 2022-09-30 NP Catalyst Pharmaceutical Partners EC US14888U1016 60,000 -65,000 -52.00 770 -12.21 0.1485
2022-08-29 2022-06-30 NP Catalyst Pharmaceutical Partners EC US14888U1016 125,000 60,000 92.31 876 62.83 0.1728
2022-05-26 2022-03-31 NP Catalyst Pharmaceutical Partners EC US14888U1016 65,000 0 0.00 539 22.27 0.1270
2022-02-28 2021-12-31 NP Catalyst Pharmaceutical Partners EC US14888U1016 65,000 -55,000 -45.83 440 -30.82 0.1230
2021-11-29 2021-09-30 NP Catalyst Pharmaceutical Partners EC US14888U1016 120,000 0 0.00 636 -7.83 0.1656
2021-08-27 2021-06-30 NP Catalyst Pharmaceutical Partners EC US14888U1016 120,000 120,000 690 0.1671
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.